SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-14-002988
Filing Date
2014-05-08
Accepted
2014-05-08 17:01:20
Documents
6
Period of Report
2014-06-19
Effectiveness Date
2014-05-08

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 14A def14a0514_soligenix.htm DEF 14A 386803
2 img01.jpg GRAPHIC 1112
3 img02.jpg GRAPHIC 924
4 img03.jpg GRAPHIC 75778
5 img04.jpg GRAPHIC 202527
6 img05.jpg GRAPHIC 213106
  Complete submission text file 0001213900-14-002988.txt   1068547
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-16929 | Film No.: 14825814
SIC: 2834 Pharmaceutical Preparations